Realty Income: Raised Guidance, Higher Growth Expectations Reinforces The Bull Case For Income Investors
Realty Income trades at a discounted 14x forward P/AFFO, below the sector median, offering attractiv…
seekingalpha.com
AZTA(AZTA)
AZTA
Next earnings: Aug 4, 2026 · Before open
Signal
Mixed1↑1↓
PRICE
Prev Close
16.80
Open
16.57
Day Range15.96 – 16.69
15.96
16.69
52W Range15.96 – 41.73
15.96
41.73
0% of range
VOLUME & SIZE
Avg Volume
1.1M
FUNDAMENTALS
P/E Ratio
-6.7x
Not profitable
EPS (TTM)
—
Div Yield
0.00%
Beta
1.51
High vol
Performance
1D
-4.64%5D
-13.73%1M
-35.79%3M
-44.03%6M
-46.15%YTD↓
-51.83%1Y
-40.02%Worst: YTD (-51.83%)
Quick Read
Trend—Insufficient MA data
Momentum
BULLISH
45% gross marginValuation
FAIR
P/E not availableHealth
STRONG
CR 2.8 · FCF $0.62/shBullish
Key MetricsTTM
Market Cap$738.41M
Revenue TTM$596.57M
Net Income TTM-$178.16M
Free Cash Flow$28.72M
Gross Margin44.6%
Net Margin-29.9%
Operating Margin-2.6%
Return on Equity-10.7%
Return on Assets-9.4%
Debt / Equity0.04
Current Ratio2.83
EPS TTM$-3.87
Alpha SignalsView Intelligence →
Intelligence analysis not yet available for this stock. Full AI-powered analysis may be available on the intelligence page.
Health Radar
2 strong1 watch3 concern
40/100Liquidity
2.83Strong
Leverage
0.04Strong
Coverage
0.0xConcern
ROE
-10.7%Concern
ROIC
-0.7%Concern
Cash
$280MWatch
ANALYST COVERAGE11 analysts
BUY
▲ +180.9%upside to target
L $44.00
Med $45.00consensus
H $45.00Stock Health
Composite Score
2 of 5 signals bullish
4/10
Technicals
●
~RSI RangeRSI 19 — Oversold, watch for bounce
Volume
●
✗Volume FlowDistribution — institutional selling
Fundamentals
●
✗Last EarningsMissed estimates
●
✓Analyst ConsensusBuy
●
✓LiquidityCurrent Ratio 2.83 — healthy liquidity
Upcoming Events
EEarnings ReportMay 17, 2026
Tomorrow
DEx-Dividend DateAug 14, 2026
In 90 days
PDividend PaymentAug 28, 2026
In 104 days
FinancialsFull statements →
Technicals
Technical SetupBEARISH
Technicals →Trend
▼ DowntrendGolden Cross · 50D leads 200D by 18.4%
-49.3% vs SMA 50 · -39.9% vs SMA 200
Momentum
RSI19.2Oversold — potential bounce
MACD-4.77Below zero — bearish pulse · compressing
Market Position
Price Levels
52W High
$41.73+160.5%
EMA 50
$28.94+80.6%
EMA 200
$26.56+65.8%
Current
$16.02
52W Low
$15.96-0.4%
52-Week RangeNear 52-week low
$15.960th %ile$41.73
Squeeze SetupVolume-based
Distribution PressureHeavy distribution on elevated volume — institutions appear to be exiting. Squeeze setups unlikely while selling pressure persists.
20-Day Money Flow
Acc days:2
Dist days:5
Edge:+3 dist
Volume Context
Avg Vol (50D)1.1M
Recent Vol (5D)
1.3M+12%
Based on volume distribution analysis. Direct short interest data (short float %, days to cover) is not available in current data sources.
Earnings & Analysts
ANALYST ESTIMATES
Consensus of 4 analysts
Analyst revisions:EPS↑ Revised UpRevenue↓ Revised Down
Analyst consensus estimates · Actuals replace estimates as reported
| Year | Revenue Est. | Rev Gth | EPS Est. | EPS Gth | Range | Analysts |
|---|---|---|---|---|---|---|
FY2025 | $591.0M $589.1M–$593.0M | — | $0.50 | — | ±2% | Moderate4 |
FY2026(current) | $600.5M $589.6M–$603.8M | ▲ +1.6% | $0.45 | ▼ -10.8% | ±2% | Moderate4 |
FY2027 | $629.5M $618.1M–$633.1M | ▲ +4.8% | $0.61 | ▲ +37.0% | ±2% | Moderate4 |
Range confidence:Tight (high)ModerateWide (low)
Earnings HistoryAZTA
Last 8Q
+13.3%avg beat
Beat 5 of 8 quartersMissed 3↑ Estimates rising+129%
Q3'24
+64%
Q4'24
+60%
Q1'25
-44%
Q2'25
+46%
Q3'25
+11%
Q4'25
-18%
Q1'26
-140%
Q2'26
Beat
Miss
Estimate
Deeper color = bigger beat/miss
* Negative EPS shown at reduced heightAnalyst Activity
All ratings →No recent activity
Evercore ISIOutperform
Jan 5
UPGRADE
JefferiesHold → Buy
Oct 30
UPGRADE
StephensBuy → Overweight
Dec 18
UPGRADE
StephensEqual-Weight
Feb 9
DOWNGRADE
Insider Activity
SEC Filings →5 Buys/1 SellNet Buying
Cornog William LDir
$75K
May 20
BUY
Cornog William LDir
$112K
May 19
BUY
Cornog William LDir
$3K
May 16
BUY
Pirogova OlgaSVP and CHRO
$31K
Aug 12
SELL
Marotta JohnDir
$26K
Jun 2
BUY
Malus Alan JDir
$320K
May 30
BUY
Financials
INSTITUTIONAL OWNERSHIP
1
BlackRock, Inc.
6.7M▼2
Politan Capital Management LP
4.6M▲3
Conestoga Capital Advisors, LLC
2.8M▲4
DIMENSIONAL FUND ADVISORS LP
2.1M▼5
MASSACHUSETTS FINANCIAL SERVICES CO /MA/
1.8M▲6
STATE STREET CORP
1.8M▲7
Allspring Global Investments Holdings, LLC
1.6M▲8
AMERICAN CAPITAL MANAGEMENT INC
1.3M▲News & Activity
AZTA News
20 articles · 4h ago
VPU: Utilities Dashboard For May
seekingalpha.com
Peloton Stock Gives Back Gains After Upbeat Earnings Report
marketbeat.com
Buy Nvidia Under $250 on Trump's China Visit and Warsh's Dovish AI Signals
247wallst.com
High Liner Foods Q1 Earnings Call Highlights
marketbeat.com
i-80 Gold Q1 Earnings Call Highlights
marketbeat.com
Gunnison Copper appoints Craig Hallworth as CEO - ICYMI
proactiveinvestors.com
Bayanat Engineering Brings Advanced Meteorological Sensing to Dubai's First Commercial eVTOL Vertiport
globenewswire.com
Alpine Income Property: Why This 6.4% Yield Has Upside Potential
seekingalpha.com
Creator content made the main stage at TV's 'upfront' pitches — and not just for YouTube
cnbc.com
Cerebras' blockbuster IPO boosts hype for SpaceX and OpenAI, but crowds out smaller players
cnbc.com
Black Rock Coffee Bar Continues Expansion in Phoenix with Two New Locations
globenewswire.com
The Rosen Law Firm, P.A. Announces Proposed Class Action Settlement on Behalf of Purchasers of Sun Communities, Inc. Publicly-Traded Common Stock - SUI
globenewswire.com
VVC Exploration Corporation Announces Application For Management Cease Trade Order And Provides Financing Update
globenewswire.com
The Rosen Law Firm, P.A. Announces Proposed Class Action Settlement on Behalf of Purchasers of Sun Communities, Inc. Publicly-Traded Common Stock - SUI
globenewswire.com
Black Rock Coffee Bar Continues Expansion in Phoenix with Two New Locations
globenewswire.com
Ipsen presents first-in-class late-breaking Phase II corabotase data in glabellar lines showing sustained duration of effect reinforced by consistently high patient satisfaction
globenewswire.com
VVC Exploration Corporation Announces Application For Management Cease Trade Order And Provides Financing Update
globenewswire.com
Schwab Remains Highly Attractive
seekingalpha.com
Ipsen présente les derniers résultats d'une étude de phase II sur la corabotase, première de sa classe, concernant les rides glabellaires, montrant une durée d'effet prolongée et un niveau de satisfaction constamment élevé chez les patients
globenewswire.com
About
azenta (nasdaq: azta) is a leading provider of life sciences solutions worldwide, enabling impactful breakthroughs and therapies to market faster. azenta provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. azenta is headquartered in chelmsford, ma, with operations in north america, europe and asia. for more information, please visit www.azenta.com.
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
CEO
Stephen Schwartz
Website
Ephraim StarrSenior Vice President, General Counsel & Corporate Secretary
John MarottaPresident, Chief Executive Officer & Director
Lawrence Y. LinExecutive Vice President & Chief Financial Officer
Peers— Health Care(7 companies)
Screen sector →| Symbol | Price | Day % | Mkt Cap↓ | P/E | Rev Grw | Margin | ELO |
|---|---|---|---|---|---|---|---|
AZTA◀ | $16.02 | -4.64% | $738M | — | +355.3% | -939.1% | 1500 |
| $66.13 | -5.07% | $13.0B | — | +12626.1% | -14525.8% | 1500 | |
| $94.92 | -3.79% | $12.6B | — | +3288.2% | -4239.0% | 1500 | |
| $523.69 | -3.00% | $12.1B | — | +43205.3% | -3008.0% | 1500 | |
| $227.72 | -1.30% | $11.7B | — | +6554.5% | -2868.8% | 1500 | |
| $57.90 | -0.86% | $11.2B | 50.3 | +1459.3% | 147.7% | 1500 | |
| $76.67 | -3.79% | $10.8B | — | +2325815.3% | -19.7% | 1500 | |
| Sector avg | — | -3.21% | — | 50.3 | +341900.6% | -3636.1% | 1500 |